Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Creon 25000 MMS in PEI After Pancreatic Surgery
NCT00535756Phase 4Completed
- Sponsor
- Abbott Laboratories
- Start
- Apr 2008
- Primary completion
- Jun 2011
- Modality
- Replacement Enzymes
- Countries
- 4
01
Overview
A Phase 4 trial of LipaCreon in pancreatic exocrine insufficiency (EPI), sponsored by Abbott Laboratories. Started Apr 2008; status: completed.
02
Drugs
LipaCreon
03
Conditions
pancreatic exocrine insufficiency (EPI)
Beyond the preview
Go deeper on NCT00535756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00535756.